Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

Alica K. Beutel

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108824338. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 10

  1. Organoid-based precision medicine in pancreatic cancer. Co-author DOI 10.1002/ueg2.12701↗
  2. Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy. Co-author DOI 10.1002/ueg2.12773↗
  3. Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution Co-author DOI 10.1101/2025.04.24.650216↗
  4. Barriers and opportunities for gemcitabine in pancreatic cancer therapy. Co-author DOI 10.1152/ajpcell.00331.2022↗
  5. Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells. Co-author DOI 10.1038/s43018-022-00463-1↗
  6. A Prospective Feasibility Trial to Challenge Patient-Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Co-author DOI 10.3390/cancers13112539↗
  7. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. Co-author DOI 10.1177/2050640620905183↗
  8. Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy. Co-author DOI 10.3390/cells9092110↗
  9. Immunotherapy: Pancreatic Cancer and Extrahepatic Biliary Tract Cancer. First author DOI 10.1159/000497291↗
  10. A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer. Co-author DOI 10.7150/thno.29247↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander Kleger · 7 shared papers, 2019–2025 · strength 1.08
  2. Thomas Theodor Werner Seufferlein · 7 shared papers, 2019–2025 · strength 1.08
  3. Johann Gout · 6 shared papers, 2020–2025 · strength 1.01
  4. Thomas Jens Ettrich · 6 shared papers, 2019–2025 · strength 0.89
  5. Lukas Perkhofer · 6 shared papers, 2019–2025 · strength 0.88
  6. Christopher J. Halbrook · 3 shared papers, 2022–2025 · strength 0.73
  7. Élodie Roger · 4 shared papers, 2020–2025 · strength 0.64
  8. Marko Kornmann · 3 shared papers, 2019–2025 · strength 0.36
  9. Martin Müller · 3 shared papers, 2020–2021 · strength 0.30
  10. Hans Armin Kestler · 2 shared papers, 2021–2025 · strength 0.29
  11. Frank Arnold · 2 shared papers, 2020 · strength 0.19
  12. Yazid J. Resheq · 1 shared paper, 2025 · strength 0.18
  13. Nuh N. Rahbari · 1 shared paper, 2025 · strength 0.18
  14. André L. Mihaljević · 1 shared paper, 2025 · strength 0.18
  15. Dharini Srinivasan · 1 shared paper, 2025 · strength 0.18
  16. Christoph W. Michalski · 1 shared paper, 2025 · strength 0.18
  17. Bo Kong · 1 shared paper, 2025 · strength 0.18
  18. Johannes Lemke · 1 shared paper, 2021 · strength 0.11
  19. Heather R. Christofk · 1 shared paper, 2022 · strength 0.10
  20. Andrea Viale · 1 shared paper, 2022 · strength 0.10
  21. Nina G. Steele · 1 shared paper, 2022 · strength 0.10
  22. Seth Boyer · 1 shared paper, 2022 · strength 0.10
  23. Rima Singh · 1 shared paper, 2022 · strength 0.10
  24. Claus Jørgensen · 1 shared paper, 2022 · strength 0.10
  25. Marina Pasca di Magliano · 1 shared paper, 2022 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.